{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:34:03Z","timestamp":1790051643500,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,9,26]],"date-time":"2014-09-26T00:00:00Z","timestamp":1411689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s12072-014-9572-2","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T09:45:47Z","timestamp":1411638347000},"page":"550-559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Assessment of the features of serum apolipoprotein profiles in chronic HCV infection: difference between HCV genotypes 1b and 2"],"prefix":"10.1007","volume":"8","author":[{"given":"Nobuyoshi","family":"Seki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Aida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munenori","family":"Itagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruya","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Sutoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Tsubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,26]]},"reference":[{"key":"9572_CR1","unstructured":"World Health Organization. World Health Organization. Media Centre. July 2013. http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/"},{"key":"9572_CR2","unstructured":"Murray R, Bender D. Botham KM, Kennelly PJ, Rodwell V, Weil PA. Harper\u2019s Illustrated Biochemistry. 29th ed. US: McGraw-Hill Medical; 2012"},{"key":"9572_CR3","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1128\/JVI.80.5.2418-2428.2006","volume":"80","author":"SU Nielsen","year":"2006","unstructured":"Nielsen SU, Bassendine MF, Burt AD, Martin C, Pumeechockchai W, Toms GL. Association between hepatitis C virus and very-low-density lipoprotein (VLDL)\/LDL analyzed in iodixanol density gradients. J Virol 2006;80:2418\u20132428","journal-title":"J Virol"},{"key":"9572_CR4","doi-asserted-by":"crossref","first-page":"e67982","DOI":"10.1371\/journal.pone.0067982","volume":"8","author":"J Jiang","year":"2013","unstructured":"Jiang J, Wu X, Tang H, Luo G. Apolipoprotein E mediates attachment of clinical hepatitis C virus to hepatocytes by binding to cell surface heparan sulfate proteoglycan receptors. PLoS One 2013;8(7):e67982","journal-title":"PLoS One"},{"key":"9572_CR5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/gut.2004.050302","volume":"54","author":"L Fartoux","year":"2005","unstructured":"Fartoux L, Poujol-Robert A, Gu\u00e9chot J, Wendum D, Poupon R, Serfaty L. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 2005;54:1003\u20131008","journal-title":"Gut"},{"key":"9572_CR6","first-page":"263","volume":"69","author":"D Yamane","year":"2013","unstructured":"Yamane D, McGivern DR, Masaki T, Lemon SM. Liver injury and disease pathogenesis in chronic hepatitis C. Curr Top Microbiol Immunol 2013;69:263\u2013288","journal-title":"Curr Top Microbiol Immunol"},{"key":"9572_CR7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/jvh.12209","volume":"21","author":"\u00c1JA Rojas","year":"2014","unstructured":"Rojas \u00c1JA, del Campo JA, Maraver M, Aparcero R, Garc\u00eda-Valdecasas M, Diago M, et al. Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro. J Viral Hepat 2014;21:19\u201324","journal-title":"J Viral Hepat"},{"key":"9572_CR8","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/infdis\/171.6.1607","volume":"171","author":"JM Pawlotsky","year":"1995","unstructured":"Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995;171:1607\u20131610","journal-title":"J Infect Dis"},{"key":"9572_CR9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12072-011-9291-x","volume":"6","author":"J Rowell","year":"2012","unstructured":"Rowell J, Thompson AJ, Guyton JR, Lao XQ, McHutchison JG, McCarthy JJ, et al. Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis. Hepatol Int 2012;6:475\u2013481","journal-title":"Hepatol Int"},{"key":"9572_CR10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1386-6346(02)00309-1","volume":"25","author":"K Moriya","year":"2003","unstructured":"Moriya K, Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Yotsuyanagi H, et al. Serum lipid profile of patients with genotype 1b hepatitis C viral infection in Japan. Hepatol Res 2003;25:371\u2013376","journal-title":"Hepatol Res"},{"key":"9572_CR11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0168-8278(00)00036-2","volume":"34","author":"L Serfaty","year":"2001","unstructured":"Serfaty L, Andreani T, Giral P, Carbonell N, Chazouill\u00e8res O, Poupon R. Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. J Hepatol 2001;34:428\u2013434","journal-title":"J Hepatol"},{"key":"9572_CR12","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/gut.2010.222133","volume":"60","author":"SH Bridge","year":"2011","unstructured":"Bridge SH, Sheridan DA, Felmlee DJ, Nielsen SU, Thomas HC, Taylor-Robinson SD, et al. Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection. Gut 2011;60:680\u2013687","journal-title":"Gut"},{"key":"9572_CR13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1096\/fj.01-0396com","volume":"16","author":"G Perlemuter","year":"2002","unstructured":"Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chr\u00e9tien Y, et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 2002;16:185\u2013194","journal-title":"FASEB J"},{"key":"9572_CR14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1440-1746.1993.tb01507.x","volume":"8","author":"K Chayama","year":"1993","unstructured":"Chayama K, Tsubota A, Arase Y, et al. Genotypic subtyping of hepatitis C virus. J Gastroenterol Hepatol 1993;8:150\u2013156","journal-title":"J Gastroenterol Hepatol"},{"key":"9572_CR15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/(SICI)1096-9071(199910)59:2<141::AID-JMV3>3.0.CO;2-5","volume":"59","author":"H Fujie","year":"1999","unstructured":"Fujie H, Yotsuyanagi H, Moriya K, Shintani Y, Tsutsumi T, Takayama T, et al. Steatosis and intrahepatic hepatitis C virus in chronic hepatitis. J Med Virol 1999;59:141\u2013145","journal-title":"J Med Virol"},{"key":"9572_CR16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00535-012-0610-3","volume":"48","author":"I Miyajima","year":"2013","unstructured":"Miyajima I, Kawaguchi T, Fukami A, Nagao Y, Adachi H, Sasaki S, et al. Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: a population-based study in an HCV hyperendemic area. J Gastroenterol 2013;48:93\u2013100","journal-title":"J Gastroenterol"},{"key":"9572_CR17","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s12072-011-9273-z","volume":"7","author":"S Sato","year":"2011","unstructured":"Sato S, Genda T, Hirano K, Tsuzura H, Kanemitsu Y, Narita Y, et al. Differences in the factors associated with serum viral load between genotypes 1 and 2 in patients with chronic hepatitis C. Hepatol Int 2013;7:508\u2013515","journal-title":"Hepatol Int"},{"key":"9572_CR18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00281-012-0356-2","volume":"35","author":"MF Bassendine","year":"2013","unstructured":"Bassendine MF, Sheridan DA, Bridge SH, Felmlee DJ, Neely RD. Lipids and HCV. Semin Immunopathol 2013;35:87\u2013100","journal-title":"Semin Immunopathol"},{"key":"9572_CR19","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1099\/0022-1317-77-12-3013","volume":"77","author":"P Simmonds","year":"1996","unstructured":"Simmonds P, Mellor J, Sakuldamrongpanich T, Nuchaprayoon C, Tanprasert S, Holmes EC, et al. Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol 1996;77:3013\u20133024","journal-title":"J Gen Virol"},{"key":"9572_CR20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499\u2013502","journal-title":"Clin Chem."},{"key":"9572_CR21","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 2006;43:1317\u20131325","journal-title":"Hepatology"},{"key":"9572_CR22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 2007;46:32\u201336","journal-title":"Hepatology"},{"key":"9572_CR23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/01.CIR.92.3.364","volume":"92","author":"M Syv\u00e4nne","year":"1995","unstructured":"Syv\u00e4nne M, Kahri J, Virtanen KS, Taskinen MR. HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus. Circulation 1995;92:364\u2013370","journal-title":"Circulation"},{"key":"9572_CR24","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1016\/j.febslet.2009.07.034","volume":"583","author":"K Kim","year":"2009","unstructured":"Kim K, Kim KH, Ha E, Park JY, Sakamoto N, Cheong J. Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma. FEBS Lett 2009;583:2720\u20132726","journal-title":"FEBS Lett"},{"key":"9572_CR25","first-page":"819","volume":"21","author":"P Thulin","year":"2008","unstructured":"Thulin P, Glinghammar B, Skogsberg J, Lundell K, Ehrenborg E. PPARdelta increases expression of the human apolipoprotein A-II gene in human liver cells. Int J Mol Med 2008;21:819\u2013824","journal-title":"Int J Mol Med"},{"key":"9572_CR26","doi-asserted-by":"crossref","first-page":"E1568","DOI":"10.1210\/jc.2011-1131","volume":"96","author":"EM Ooi","year":"2011","unstructured":"Ooi EM, Watts GF, Sprecher DL, Chan DC, Barrett PH. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity. J Clin Endocrinol Metab 2011;96:E1568\u2013E1576","journal-title":"J Clin Endocrinol Metab"},{"key":"9572_CR27","doi-asserted-by":"crossref","first-page":"13470","DOI":"10.1074\/jbc.270.22.13470","volume":"270","author":"R Hertz","year":"1995","unstructured":"Hertz R, Bishara-Shieban J, Bar-Tana J. Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. J Biol Chem 1995;270:13470\u201313475","journal-title":"J Biol Chem"},{"key":"9572_CR28","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1128\/JVI.01815-13","volume":"88","author":"K Hueging","year":"2014","unstructured":"Hueging K, Doepke M, Vieyres G, Bankwitz D, Frentzen A, Doerrbecker J, et al. Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly. J Virol 2014;88:1433\u20131446","journal-title":"J Virol"},{"key":"9572_CR29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jhep.2012.02.017","volume":"57","author":"DA Sheridan","year":"2012","unstructured":"Sheridan DA, Bridge SH, Felmlee DJ, Crossey MM, Thomas HC, Taylor-Robinson SD, et al. Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: evidence for an association with interferon sensitivity. J Hepatol 2012;57:32\u201338","journal-title":"J Hepatol"},{"key":"9572_CR30","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/jmv.23597","volume":"85","author":"K Yoshizawa","year":"2013","unstructured":"Yoshizawa K, Abe H, Aida Y, Ishiguro H, Ika M, Shimada N, et al. Serum apolipoprotein B-100 concentration predicts the virological response to pegylated interferon plus ribavirin combination therapy in patients infected with chronic hepatitis C virus genotype 1b. J Med Virol 2013;85:1180\u20131190","journal-title":"J Med Virol"},{"key":"9572_CR31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11010-011-1037-5","volume":"360","author":"Y Aizawa","year":"2012","unstructured":"Aizawa Y, Yoshizawa K, Aida Y, Ishiguro H, Abe H, Tsubota A. Genotype rs8099917 near the IL28B gene and amino acid substitution at position 70 in the core region of the hepatitis C virus are determinants of serum apolipoprotein B-100 concentration in chronic hepatitis C. Mol Cell Biochem 2012;360:9\u201314","journal-title":"Mol Cell Biochem"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-014-9572-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-014-9572-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-014-9572-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T22:59:37Z","timestamp":1598309977000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-014-9572-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,26]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["9572"],"URL":"https:\/\/doi.org\/10.1007\/s12072-014-9572-2","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,26]]}}}